Ceftazidime for Injection USP and Dextrose for recall
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524…
Why was Ceftazidime for Injection USP and Dextrose for recalled?
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: H8J812, Exp. Date 31 JUL 2020
- Product
- Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524…
- Recalling firm
- B. Braun Medical Inc
- Quantity
- 22,488 Duplex containers
- Distribution
- Product was distributed nationwide within the United States.
- Recall date
- May 6, 2020
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)